Elevai Labs, Inc. (ELAB)
NASDAQ: ELAB · IEX Real-Time Price · USD
0.500
-0.005 (-0.91%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Elevai Labs Employees
Elevai Labs had 18 employees as of December 31, 2023.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
$121,352
Profits / Employee
-$256,566
Market Cap
9.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PAVmed | 107 |
| Tonix Pharmaceuticals Holding | 103 |
| Pieris Pharmaceuticals | 50 |
| Plus Therapeutics | 20 |
| ABVC BioPharma | 19 |
| Nexalin Technology | 6 |
| Mangoceuticals | 3 |
| Silo Pharma | 3 |
ELAB News
- 6 days ago - Top 4 Risk Off Stocks You'll Regret Missing In July - Benzinga
- 5 weeks ago - Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs - GlobeNewsWire
- 2 months ago - Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference - GlobeNewsWire
- 2 months ago - Elevai Labs Inc. Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity - GlobeNewsWire
- 2 months ago - Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare - GlobeNewsWire
- 2 months ago - Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments - GlobeNewsWire
- 2 months ago - Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments - GlobeNewsWire